Correlation Between Nephros and Utah Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nephros and Utah Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nephros and Utah Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nephros and Utah Medical Products, you can compare the effects of market volatilities on Nephros and Utah Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nephros with a short position of Utah Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nephros and Utah Medical.

Diversification Opportunities for Nephros and Utah Medical

0.58
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Nephros and Utah is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Nephros and Utah Medical Products in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Utah Medical Products and Nephros is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nephros are associated (or correlated) with Utah Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Utah Medical Products has no effect on the direction of Nephros i.e., Nephros and Utah Medical go up and down completely randomly.

Pair Corralation between Nephros and Utah Medical

Given the investment horizon of 90 days Nephros is expected to under-perform the Utah Medical. In addition to that, Nephros is 2.12 times more volatile than Utah Medical Products. It trades about -0.12 of its total potential returns per unit of risk. Utah Medical Products is currently generating about -0.02 per unit of volatility. If you would invest  6,646  in Utah Medical Products on September 2, 2024 and sell it today you would lose (121.00) from holding Utah Medical Products or give up 1.82% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Nephros  vs.  Utah Medical Products

 Performance 
       Timeline  
Nephros 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nephros has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Utah Medical Products 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Utah Medical Products has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, Utah Medical is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Nephros and Utah Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nephros and Utah Medical

The main advantage of trading using opposite Nephros and Utah Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nephros position performs unexpectedly, Utah Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Utah Medical will offset losses from the drop in Utah Medical's long position.
The idea behind Nephros and Utah Medical Products pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Global Correlations
Find global opportunities by holding instruments from different markets